Abstract
We present the first crystal structures of a human protein bound to analogs of cocaine and heroin. Human carboxylesterase 1 (hCE1) is a broad-spectrum bioscavenger that catalyzes the hydrolysis of heroin and cocaine, and the detoxification of organophosphate chemical weapons, such as sarin, soman and tabun. Crystal structures of the hCE1 glycoprotein in complex with the cocaine analog homatropine and the heroin analog naloxone provide explicit details about narcotic metabolism in humans. The hCE1 active site contains both specific and promiscuous compartments, which enable the enzyme to act on structurally distinct chemicals. A selective surface ligand-binding site regulates the trimer-hexamer equilibrium of hCE1 and allows each hCE1 monomer to bind two narcotic molecules simultaneously. The bioscavenger properties of hCE1 can likely be used to treat both narcotic overdose and chemical weapon exposure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Satoh, T. & Hosokawa, M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 38, 257–288 (1998).
Satoh, T. et al. Current progress on esterases: from molecular structure to function. Drug Metab. Dispos. 30, 488–493 (2002).
Brzezinski, M.R. et al. Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab. Dispos. 25, 1089–1096 (1997).
Brzezinski, M.R., Abraham, T.R., Stone, C.L., Dean, R.A. & Bosron, W.F. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem. Pharmacol. 48, 1747–1755 (1994).
Tang, B.K. & Kalow, W. Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. Eur. J. Clin. Pharmacol. 47, 449–451 (1995).
Alexson, S.E., Diczfalusy, M., Halldin, M. & Swedmark, S. Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine. Drug Metab. Dispos. 30, 643–647 (2002).
Takai, S. et al. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biol. Pharm. Bull. 20, 869–873 (1997).
Ellgaard, L., Molinari, M. & Helenius, A. Setting the standards: quality control in the secretory pathway. Science 286, 1882–1888 (1999).
Sweeney, R.E. & Maxwell, D.M. A theoretical model of the competition between hydrolase and carboxylesterase in protection against organophosphorus poisoning. Math. Biosci. 160, 175–190 (1999).
Broomfield, C.A. & Kirby, S.D. Progress on the road to new nerve agent treatments. J. Appl. Toxicol. 21 Suppl. 1, S43–S46 (2001).
Maxwell, D.M. & Brecht, K.M. Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. J. Appl. Toxicol. 21 Suppl. 1, S103–S107 (2001).
Pindel, E.V. et al. Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem. 272, 14769–14775 (1997).
Kamendulis, L.M., Brzezinski, M.R., Pindel, E.V., Bosron, W.F. & Dean, R.A. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J. Pharmacol. Exp. Ther. 279, 713–717 (1996).
Sun, H., Shen, M.L., Pang, Y.P., Lockridge, O. & Brimijoin, S. Re-engineering butyrylcholinesterase as a cocaine hydrolase. J. Pharmacol. Exp. Ther. 302, 710–716 (2002).
Pennings, E.J., Leccese, A.P. & Wolff, F.A. Effects of concurrent use of alcohol and cocaine. Addiction 97, 773–783 (2002).
Bencharit, S. et al. Structural insights into CPT-11 activation by mammalian carboxylesterases. Nat. Struct. Biol. 9, 337–342 (2002).
Leszczynski, J.F. & Rose, G.D. Loops in globular proteins: a novel category of secondary structure. Science 234, 849–855 (1986).
Kryger, G. et al. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr. D 56, 1385–1394 (2000).
Mori, M., Hosokawa, M., Ogasawara, Y., Tsukada, E. & Chiba, K. cDNA cloning, characterization and stable expression of novel human brain carboxylesterase. FEBS Lett. 458, 17–22 (1999).
Dean, R.A., Zhang, J., Brzezinski, M.R. & Bosron, W.F. Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein. J. Pharmacol. Exp. Ther. 275, 965–971 (1995).
Kalasinsky, K.S. et al. Regional distribution of cocaine in postmortem brain of chronic human cocaine users. J. Forensic Sci. 45, 1041–1048 (2000).
Larsen, N.A. et al. Crystal structure of a bacterial cocaine esterase. Nat. Struct. Biol. 9, 17–21 (2002).
Larsen, N.A. et al. Crystal structure of a cocaine-binding antibody. J. Mol. Biol. 311, 9–15 (2001).
Bosron, W.F. & Hurley, T.D. Lessons from a bacterial cocaine esterase. Nat. Struct. Biol. 9, 4–5 (2002).
Kroetz, D.L., McBride, O.W. & Gonzalez, F.J. Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry 32, 11606–11617 (1993).
Suzuki-Kurasaki, M., Yoshioka, T. & Uematsu, T. Purification and characterization of guinea-pig liver microsomal deacetylase involved in the deacetylation of the O-glucoside of N-hydroxyacetanilide. Biochem. J. 325, 155–161 (1997).
Broomfield, C.A. et al. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther. 259, 633–638 (1991).
Morton, C.L. & Potter, P.M. Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression: application to a rabbit liver carboxylesterase. Mol. Biotechnol. 16, 193–202 (2000).
Danks, M.K. et al. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. Clin. Cancer Res. 5, 917–924 (1999).
Collaborative Computing Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
Otwinowski, Z. & Minor, W. Data collection and processing (Daresbury Laboratories, Warrington; 1993).
Navaza, J. Implementation of molecular replacement in AMoRe. Acta Crystallogr. D 57, 1367–1372 (2001).
Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Read, R.J. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. A 42, 140–149 (1986).
Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946–950 (1991).
Esnouf, R.M. Further additions to MolScript version 1. 4, including reading and contouring of electron-density maps. Acta Crystallogr. D 55, 938–940 (1999).
Merritt, E.A. & Murphy, M.E.P. Raster3D version 2. 0 — a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869–873 (1991).
Ratcliff, G.C. & Erie, D.A. A novel single-molecule study to determine protein-protein association constants. J. Am. Chem. Soc. 123, 5632–5635 (2001).
Acknowledgements
We thank G. Pielak, L. Spremulli, B. Bernstein and C. Kuhn for critical comments on the manuscript; P. Kuhn and J. Chrzas for help with data collection; D. Erie for access to AFM equipment; and members of the Redinbo Laboratory, including J. Chrencik, E. Howard-Williams, T. Lesher, S. Sakai and R. Watkins, for discussions and experimental assistance. The reseach was supported by the N.I.H. and a Burroughs Wellcome Career Award in the Biomedical Sciences (M.R.R), and by the N.I.H. (including a Core Grant) and the American Lebanese Syrian Associated Charities (P.M.P.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bencharit, S., Morton, C., Xue, Y. et al. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat Struct Mol Biol 10, 349–356 (2003). https://doi.org/10.1038/nsb919
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsb919
This article is cited by
-
Inhibition of human carboxylesterases by ginsenosides: structure–activity relationships and inhibitory mechanism
Chinese Medicine (2019)
-
Cholinesterase and carboxylesterase inhibitors as pharmacological agents
Russian Chemical Bulletin (2019)
-
Structural and chemical biology of deacetylases for carbohydrates, proteins, small molecules and histones
Communications Biology (2018)
-
Carboxylesterases in lipid metabolism: from mouse to human
Protein & Cell (2018)
-
Improvement of the self-consistent-charge density-functional-tight-binding theory by a modified Mulliken charge
Theoretical Chemistry Accounts (2017)